Share on StockTwits

Vernalis plc (LON:VER)‘s stock had its “buy” rating reiterated by equities researchers at Canaccord Genuity in a research report issued on Wednesday, Analyst Ratings.Net reports. They currently have a GBX 52 ($0.88) price target on the stock. Canaccord Genuity’s price objective suggests a potential upside of 69.11% from the stock’s previous close.

Shares of Vernalis plc (LON:VER) opened at 30.75 on Wednesday. Vernalis plc has a 52 week low of GBX 18.75 and a 52 week high of GBX 38.00. The stock’s 50-day moving average is GBX 34.56 and its 200-day moving average is GBX 34.23.

A number of other firms have also recently commented on VER. Analysts at Nplus1 Brewin reiterated a “buy” rating on shares of Vernalis plc in a research note on Thursday, April 24th. They now have a GBX 42 ($0.71) price target on the stock. Separately, analysts at N+1 Singer reiterated a “buy” rating on shares of Vernalis plc in a research note on Thursday, April 24th. They now have a GBX 42 ($0.71) price target on the stock. Finally, analysts at Edison Group reiterated a “positive” rating on shares of Vernalis plc in a research note on Monday, April 14th.

Vernalis plc is a research and development-stage pharmaceutical company. Vernalis has one marketed product and a portfolio of development and drug discovery programmes.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.